Douglas Abel
2009
In 2009, Douglas Abel earned a total compensation of $214.4K as Chief Executive Officer and President at TG Therapeutics, a 59% decrease compared to previous year.
Compensation breakdown
| Option Awards | $44,412 |
|---|---|
| Salary | $164,063 |
| Other | $5,896 |
| Total | $214,371 |
Abel received $164.1K in salary, accounting for 77% of the total pay in 2009.
Abel also received $44.4K in option awards and $5.9K in other compensation.
Rankings
In 2009, Douglas Abel's compensation ranked 9,115th out of 9,885 executives tracked by ExecPay. In other words, Abel earned more than 7.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,115 out of 9,885 | 8th |
Division Manufacturing | 3,436 out of 3,690 | 7th |
Major group Chemicals And Allied Products | 799 out of 866 | 8th |
Industry group Drugs | 586 out of 638 | 8th |
Industry Pharmaceutical Preparations | 414 out of 446 | 7th |
Source: SEC filing on March 22, 2011.
Abel's colleagues
We found one more compensation record of an executive who worked with Douglas Abel at TG Therapeutics in 2009.
2009
Michael McGuinness
TG Therapeutics